Matches in Wikidata for { <http://www.wikidata.org/entity/Q69074850> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q69074850 description "artículu científicu espublizáu en xunetu de 1989" @default.
- Q69074850 description "im Juli 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69074850 description "scientific article published on 01 July 1989" @default.
- Q69074850 description "wetenschappelijk artikel" @default.
- Q69074850 description "наукова стаття, опублікована в липні 1989" @default.
- Q69074850 name "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 name "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 type Item @default.
- Q69074850 label "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 label "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 prefLabel "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 prefLabel "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 P1433 Q69074850-EF4998E1-A850-408A-9D70-137B765C21AB @default.
- Q69074850 P1476 Q69074850-AB51D1A5-2FB4-4B03-A813-9803246DC5C2 @default.
- Q69074850 P2093 Q69074850-2711402B-B2E8-4931-B449-E991FA56CF8C @default.
- Q69074850 P2093 Q69074850-7943984C-CA7E-48A1-9AAA-D199D3507F8D @default.
- Q69074850 P2093 Q69074850-9A77DEC8-B99A-4400-A741-21AA2B1630BA @default.
- Q69074850 P2093 Q69074850-AEA69DC0-955E-4AB7-9851-177316F4B5B3 @default.
- Q69074850 P2093 Q69074850-B1C2C219-277F-4875-B6A3-465A4A08246B @default.
- Q69074850 P2093 Q69074850-E35F127B-DAE9-4131-9923-FDC2F3AA1351 @default.
- Q69074850 P304 Q69074850-53843024-E677-41E4-B59E-B1A8705F7093 @default.
- Q69074850 P31 Q69074850-E7C8CE26-98BF-4302-A9FA-63CBAEEAF62B @default.
- Q69074850 P407 Q69074850-35CD965D-AC63-4C72-9803-09DE5A2A8BF7 @default.
- Q69074850 P433 Q69074850-7F83AD12-B00B-4109-A13A-5F045AAF829A @default.
- Q69074850 P478 Q69074850-72AA3558-B8F7-4D77-8458-2B5638AE1CBB @default.
- Q69074850 P577 Q69074850-9D8065FE-88D1-4EC7-B685-9FCEE03C31F6 @default.
- Q69074850 P698 Q69074850-14E7D886-5996-4C88-913F-A405485530CA @default.
- Q69074850 P698 2471587 @default.
- Q69074850 P1433 Q326097 @default.
- Q69074850 P1476 "Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens" @default.
- Q69074850 P2093 "Fisch P" @default.
- Q69074850 P2093 "Hank JA" @default.
- Q69074850 P2093 "Prieve AF" @default.
- Q69074850 P2093 "Sondel PM" @default.
- Q69074850 P2093 "Sosman JA" @default.
- Q69074850 P2093 "Weil-Hillman G" @default.
- Q69074850 P304 "3680-3688" @default.
- Q69074850 P31 Q13442814 @default.
- Q69074850 P407 Q1860 @default.
- Q69074850 P433 "13" @default.
- Q69074850 P478 "49" @default.
- Q69074850 P577 "1989-07-01T00:00:00Z" @default.
- Q69074850 P698 "2471587" @default.